Incyte (INCY) Retained Earnings (2010 - 2026)

Incyte (INCY) reported Retained Earnings of $517.1 million for Q1 2026, up 156.53% on a YoY basis from $201.6 million in Q1 2025, and up 141.9% quarter-over-quarter from $213.8 million in Q4 2025.

Incyte (INCY) Retained Earnings (2010 - 2026) Analysis & Trends

Incyte has reported Retained Earnings for 17 years, with the latest figure at $517.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Retained Earnings rose 156.53% year-over-year to $517.1 million; the trailing twelve-month figure through Mar 2026 stood at $517.1 million (up 156.53% YoY), and the FY2025 full-year result was $213.8 million, up 119.92% from the prior year.
  • Retained Earnings for Q1 2026 stood at $517.1 million, up from $213.8 million in the prior quarter.
  • The five-year high for Retained Earnings was $517.1 million in Q1 2026, with the low at -$1.4 billion in Q2 2024.
  • Historically, Retained Earnings has averaged -$206.8 million across 5 years, with a median of -$6.2 million in 2024.
  • Annual changes were most pronounced in 2023 — Retained Earnings soared 204.32% — and 2025, when it plunged 14719.8%.
  • Incyte's Retained Earnings stood at $15.1 million in 2022, then retreated by 13.03% to $13.1 million in 2023, then tumbled by 8286.18% to -$1.1 billion in 2024, then soared by 119.92% to $213.8 million in 2025, then surged by 141.9% to $517.1 million in 2026.
  • The last three Retained Earnings figures came in at $517.1 million (Q1 2026), $213.8 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -153.89 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -211.85 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 130.89 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -279.00 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -1.88
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 14.59 Bn
9 Abivax 91.96 Bn 91.96 Bn - -838.07 Mn
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 517.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 517.10 Mn
Dec 31, 2025 213.77 Mn
Sep 30, 2025 14.56 Mn
Jun 30, 2025 13.44 Mn
Mar 31, 2025 -914.68 Mn
Dec 31, 2024 -1.07 Bn
Sep 30, 2024 15.66 Mn
Jun 30, 2024 -1.38 Bn
Mar 31, 2024 -6.17 Mn
Dec 31, 2023 13.11 Mn
Sep 30, 2023 -40.69 Mn
Jun 30, 2023 26.81 Mn
Mar 31, 2023 -415.51 Mn
Dec 31, 2022 15.07 Mn
Sep 30, 2022 -465.68 Mn
Jun 30, 2022 -25.70 Mn
Mar 31, 2022 -23.05 Mn
Dec 31, 2021 -19.45 Mn
Sep 30, 2021 -18.65 Mn
Jun 30, 2021 -18.27 Mn